Kepos Capital LP Corcept Therapeutics Inc Transaction History

Kepos Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$10.41 - $14.66 $711,710 - $1 Million	-68,368 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $141,951 - $181,054	-11,569 Reduced 14.47%	68,368 $959,000
Q1 2018 May 14, 2018	BUY	$14.59 - $25.5 $1.17 Million - $2.04 Million	79,937 New	79,937 $1.32 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.39B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.